This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brody, B A
Right arrow Articles by Marx, P A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brody, B A
Right arrow Articles by Marx, P A

 Previous Article  |  Next Article 

J Virol. 1992 June; 66(6): 3950-3954

Protein of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).

B A Brody, E Hunter, J D Kluge, R Lasarow, M Gardner and P A Marx

Department of Microbiology, University of Alabama, Birmingham 35294.

ABSTRACT

Rhesus macaques were immunized with live vaccinia virus recombinants expressing the envelope glycoproteins (gp70 and gp22) of simian type D retrovirus (SRV), serotype 1 or 3. All of the animals immunized with either the SRV-1 env or the SRV-3 env vaccinia virus recombinant developed neutralizing antibodies against the homologous SRV. In addition, both groups developed cross-reactive antibodies and were protected against an intravenous live-virus challenge with SRV-1. The four control animals immunized with a vaccinia virus recombinant expressing the G protein of respiratory syncytial virus were not protected against the same SRV-1 challenge. Although SRV-1 and SRV-3 immune sera showed cross-neutralization, they failed to neutralize a separate, more distantly related serotype, SRV-2, in an in vitro assay. These findings are consistent with the known degree of serologic and genetic relatedness of these three SRV strains.


J Virol. 1992 June; 66(6): 3950-3954




This article has been cited by other articles:

  • Wilkinson, R. C., Murrell, C. K., Guy, R., Davis, G., Hall, J. M., North, D. C., Rose, N. J., Almond, N. (2003). Persistence and Dissemination of Simian Retrovirus Type 2 DNA in Relation to Viremia, Seroresponse, and Experimental Transmissibility in Macaca fascicularis. J. Virol. 77: 10751-10759 [Abstract] [Full Text]  
  • Guzman, R. E., Kerlin, R. L., Zimmerman, T. E. (1999). Histologic Lesions in Cynomolgus Monkeys (Macaca fascicularis) Naturally Infected with Simian Retrovirus Type D: Comparison of Seropositive, Virus-Positive, and Uninfected Animals. Toxicol Pathol 27: 672-677 [Abstract]  
  • Rasko, J. E. J., Battini, J.-L., Gottschalk, R. J., Mazo, I., Miller, A. D. (1999). The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc. Natl. Acad. Sci. USA 96: 2129-2134 [Abstract] [Full Text]